Patents by Inventor Steven D. Bradway

Steven D. Bradway has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibition of transglutaminase-mediated microbial interaction with a mammalian host
    Patent number: 7135182
    Abstract: The infection of a mammalian host by a microorganism can be prevented or treated through the administration of substrates for transglutaminases or antibodies against such substrates that inhibit the transglutaminase-mediated interaction of the microorganism with the mammalian host. These compounds may be used in the identification, prevention or treatment of microbial infection of mammalian hosts such as immunocompromised or immunosuppressed humans, for example, those having AIDS or undergoing transplantation or anti-cancer therapy.
    Type: Grant
    Filed: April 8, 2002
    Date of Patent: November 14, 2006
    Assignee: Trustees of Dartmouth College
    Inventors: Paula Sundstrom, Steven D. Bradway
  • Inhibition of transglutaminase-mediated microbial interaction with a mammalian host
    Publication number: 20020122804
    Abstract: The infection of a mammalian host by a microorganism can be prevented or treated through the administration of substrates for transglutaminases or antibodies against such substrates that inhibit the transglutaminase-mediated interaction of the microorganism with the mammalian host. These compounds may be used in the identification, prevention or treatment of microbial infection of mammalian hosts such as immunocompromised or immunosuppressed humans, for example, those having AIDS or undergoing transplantation or anti-cancer therapy.
    Type: Application
    Filed: April 8, 2002
    Publication date: September 5, 2002
    Inventors: Paula Sundstrom, Steven D. Bradway
  • Inhibition of transglutaminase-mediated microbial interaction with a mammalian host
    Patent number: 6388056
    Abstract: The infection of a mammalian host by a microorganism can be prevented or treated through the administration of substrates for transglutaminases or antibodies against such substrates that inhibit the transglutaminase-mediated interaction of the microorganism with the mammalian host. These compounds may be used in the identification, prevention or treatment of microbial infection of mammalian hosts such as immunocompromised or immunosuppressed humans, for example, those having AIDS or undergoing transplantation or anti-cancer therapy.
    Type: Grant
    Filed: October 26, 1998
    Date of Patent: May 14, 2002
    Inventors: Paula Sundstrom, Steven D. Bradway